News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,746 Results
Type
Article (40083)
Company Profile (271)
Press Release (661392)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205094)
Career Advice (2020)
Deals (35532)
Drug Delivery (97)
Drug Development (81241)
Employer Resources (172)
FDA (16210)
Job Trends (14914)
News (346463)
Policy (32649)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49777)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16215)
Artificial intelligence (255)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2265)
Cardiovascular disease (174)
Career advice (1688)
Career pathing (30)
CAR-T (153)
Cell therapy (429)
Cervical cancer (19)
Clinical research (66115)
Collaboration (841)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6390)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86766)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112920)
Executive appointments (729)
FDA (17476)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (303)
GLP-1 (713)
Government (4430)
Grass and pollen (4)
Guidances (67)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16541)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13388)
Medtech (13393)
Mergers & acquisitions (19535)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1922)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (39)
Obesity (364)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57635)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20617)
Phase II (29120)
Phase III (21681)
Pipeline (1203)
Policy (142)
Postmarket research (2564)
Preclinical (8772)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22350)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (691)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (72)
Last 7 days (903)
Last 30 days (2600)
Last 365 days (32808)
2025 (10779)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46643)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37707)
2014 (31454)
2013 (26500)
2012 (28772)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38050)
Australia (6232)
California (6158)
Canada (2018)
China (524)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (81758)
Florida (912)
Georgia (206)
Idaho (58)
Illinois (539)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4584)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1729)
New Mexico (28)
New York (1747)
North Carolina (968)
North Dakota (8)
Northern California (2688)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2314)
Tennessee (101)
Texas (912)
United States (23196)
Utah (180)
Virginia (147)
Washington D.C. (63)
Washington State (555)
West Virginia (3)
Wisconsin (54)
701,746 Results for "vivaldi biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VIVALDI BIOSCIENCES’ UNIVERSAL INFLUENZA VACCINE SHOWS POTENTIAL TO BLOCK VIRUS TRANSMSSION AND DISEASE SPREAD
Study Results to be Presented at World Vaccine Congress
April 17, 2025
·
1 min read
Business
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
Viatris Inc., a global healthcare company, announced that as part of its ongoing Board refreshment efforts, Rogerio Vivaldi Coelho, M.D., has been appointed as the newest member of its Board of Directors.
June 3, 2024
·
6 min read
VIVALDI BIOSCIENCES RECEIVES GRANT TO STUDY ITS UNIVERSAL FLU VACCINE’S ABILITY TO BLOCK VIRUS TRANSMISSION
Vivaldi Biosciences today announced it has received a grant from Flu Lab to evaluate the potential of its DeltaFLU universal influenza vaccine, administered by nasal spray, to block influenza virus transmission and spread of infection and disease.
December 18, 2023
·
5 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 25, 2025
·
4 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
1 of 70,175
Next
